Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

329 ARTÍCULOS , VIENDO DEL 286 AL 300

Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease

Li C, Ebrahimi A, Schluesener H.

Ageing Res Rev. 2013 Jan;12(1):116-40. doi: 10.1016/j.arr.2012.09.002. Epub 2012 Sep 12.

Self-regulated music stimulation for persons with Alzheimer's disease: impact assessment and social validation

Lancioni GE, Singh NN, O'Reilly MF, Green VA, Ferlisi G, Ferrarese G, Zullo V, Perilli V, Cassano G, Cordiano N, Pinto K, Zonno N.

Dev Neurorehabil. 2013;16(1):17-26. doi: 10.3109/17518423.2012.707693. Epub 2012 Oct 3.

Effects of pharmacological agents, sleep deprivation, hypoxia and transcranial magnetic stimulation on electroencephalographic rhythms in rodents: towards translational challenge models for drug discovery in Alzheimer's disease

Babiloni C, Infarinato F, Aujard F, Bastlund JF, Bentivoglio M, Bertini G, Del Percio C, Fabene PF, Forloni G, Herrero Ezquerro MT, Noè FM, Pifferi F, Ros-Bernal F, Christensen DZ, Dix S, Richardson JC, Lamberty Y, Drinkenburg W, Rossini PM.

Clin Neurophysiol. 2013 Mar;124(3):437-51. doi: 10.1016/j.clinph.2012.07.023. Epub 2012 Oct 4.

Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study

Rabey JM, Dobronevsky E, Aichenbaum S, Gonen O, Marton RG, Khaigrekht M.

J Neural Transm (Vienna). 2013 May;120(5):813-9. doi: 10.1007/s00702-012-0902-z. Epub 2012 Oct 18.

Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients

Babiloni C, Del Percio C, Bordet R, Bourriez JL, Bentivoglio M, Payoux P, Derambure P, Dix S, Infarinato F, Lizio R, Triggiani AI, Richardson JC, Rossini PM.

Clin Neurophysiol. 2013 May;124(5):837-50. doi: 10.1016/j.clinph.2012.09.017. Epub 2012 Oct 23.

Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease

Gauthier S, Molinuevo JL.

Alzheimers Dement. 2013 May;9(3):326-31. doi: 10.1016/j.jalz.2011.11.005. Epub 2012 Oct 27.

Feasibility, safety and preliminary evidence of the effectiveness of a home-based exercise programme for older people with Alzheimer's disease: a pilot randomized controlled trial

Suttanon P, Hill KD, Said CM, Williams SB, Byrne KN, LoGiudice D, Lautenschlager NT, Dodd KJ.

Clin Rehabil. 2013 May;27(5):427-38. doi: 10.1177/0269215512460877. Epub 2012 Nov 1.

Combination of Aβ clearance and neurotrophic factors as a potential treatment for Alzheimer's disease

Lin LF, Liao MJ, Xue XY, Zhang W, Yan L, Cai L, Zhou XW, Zhou X, Luo HM.

Neurosci Bull. 2013 Feb;29(1):111-20. doi: 10.1007/s12264-012-1287-6. Epub 2012 Nov 21.

Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model

Hyde C, Peters J, Bond M, Rogers G, Hoyle M, Anderson R, Jeffreys M, Davis S, Thokala P, Moxham T.

Age Ageing. 2013 Jan;42(1):14-20. doi: 10.1093/ageing/afs165. Epub 2012 Nov 22.

Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors

Bolea I, Gella A, Unzeta M.

J Neural Transm (Vienna). 2013 Jun;120(6):893-902. doi: 10.1007/s00702-012-0948-y. Epub 2012 Dec 13.

Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways

Silva T, Teixeira J, Remião F, Borges F.

Angew Chem Int Ed Engl. 2013 Jan 21;52(4):1110-21. doi: 10.1002/anie.201204964. Epub 2012 Dec 20.

An overview of the use of music therapy in the context of Alzheimer's disease: a report of a French expert group

Guetin S, Charras K, Berard A, Arbus C, Berthelon P, Blanc F, Blayac JP, Bonte F, Bouceffa JP, Clement S, Ducourneau G, Gzil F, Laeng N, Lecourt E, Ledoux S, Platel H, Thomas-Anterion C, Touchon J, Vrait FX, Leger JM.

Dementia (London). 2013 Sep;12(5):619-34. doi: 10.1177/1471301212438290. Epub 2012 Mar 28.

Effectiveness of antidementia drugs in delaying Alzheimer's disease progression

Rountree SD, Atri A, Lopez OL, Doody RS.

Alzheimers Dement. 2013 May;9(3):338-45. doi: 10.1016/j.jalz.2012.01.002. Epub 2012 Oct 24.

"Keep up the good work"! A case study of the effects of a specific cognitive training in Alzheimer's disease

Cavallo M, Cavanna AE, Harciarek M, Johnston H, Ostacoli L, Angilletta C.

Neurocase. 2013;19(6):542-52. doi: 10.1080/13554794.2012.701643. Epub 2012 Jul 24.

Dying other, dying self: creating culture and meaning in palliative healthcare

McCann CJ, Adames HY.

Palliat Support Care. 2013 Aug;11(4):289-93. doi: 10.1017/S1478951512000557. Epub 2012 Aug 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias